| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | macrophage colony-stimulating factor receptor activity | 1.18e-05 | 2 | 69 | 2 | GO:0005011 | |
| GeneOntologyBiologicalProcess | anterograde synaptic vesicle transport | 5.05e-05 | 22 | 68 | 3 | GO:0048490 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cytoskeletal transport | 5.05e-05 | 22 | 68 | 3 | GO:0099514 | |
| GeneOntologyBiologicalProcess | synaptic vesicle transport along microtubule | 5.05e-05 | 22 | 68 | 3 | GO:0099517 | |
| Domain | ATP_Ca_trans_C | 7.12e-05 | 4 | 65 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 7.12e-05 | 4 | 65 | 2 | PF12424 | |
| Domain | P-type_ATPase_IIB | 7.12e-05 | 4 | 65 | 2 | IPR006408 | |
| Domain | Clathrin_mu_CS | 1.77e-04 | 6 | 65 | 2 | IPR018240 | |
| Domain | CLAT_ADAPTOR_M_1 | 1.77e-04 | 6 | 65 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 1.77e-04 | 6 | 65 | 2 | PS00991 | |
| Domain | Clathrin_mu | 5.27e-04 | 10 | 65 | 2 | IPR001392 | |
| Domain | Adap_comp_sub | 6.43e-04 | 11 | 65 | 2 | PF00928 | |
| Domain | Clathrin_sm-chain_CS | 7.70e-04 | 12 | 65 | 2 | IPR000804 | |
| Domain | CarboxyPept_regulatory_dom | 9.08e-04 | 13 | 65 | 2 | IPR014766 | |
| Domain | MHD | 9.08e-04 | 13 | 65 | 2 | PS51072 | |
| Domain | - | 9.08e-04 | 13 | 65 | 2 | 2.60.40.1120 | |
| Domain | MHD | 9.08e-04 | 13 | 65 | 2 | IPR028565 | |
| Domain | ConA-like_dom | 9.88e-04 | 219 | 65 | 5 | IPR013320 | |
| Domain | HEAT | 1.08e-03 | 58 | 65 | 3 | IPR000357 | |
| Domain | - | 1.39e-03 | 16 | 65 | 2 | 1.20.1110.10 | |
| Domain | Sulfatase_CS | 1.39e-03 | 16 | 65 | 2 | IPR024607 | |
| Domain | AP_mu_sigma_su | 1.39e-03 | 16 | 65 | 2 | IPR022775 | |
| Domain | Clat_adaptor_s | 1.39e-03 | 16 | 65 | 2 | PF01217 | |
| Domain | ATPase_P-typ_TM_dom | 1.39e-03 | 16 | 65 | 2 | IPR023298 | |
| Domain | SULFATASE_1 | 1.57e-03 | 17 | 65 | 2 | PS00523 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.57e-03 | 17 | 65 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.57e-03 | 17 | 65 | 2 | PF00689 | |
| Domain | CarboxyPept-like_regulatory | 1.57e-03 | 17 | 65 | 2 | IPR008969 | |
| Domain | SULFATASE_2 | 1.57e-03 | 17 | 65 | 2 | PS00149 | |
| Domain | Sulfatase | 1.76e-03 | 18 | 65 | 2 | PF00884 | |
| Domain | Zn_pept | 1.76e-03 | 18 | 65 | 2 | SM00631 | |
| Domain | Cation_ATPase_N | 1.76e-03 | 18 | 65 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 1.76e-03 | 18 | 65 | 2 | SM00831 | |
| Domain | Sulfatase_N | 1.76e-03 | 18 | 65 | 2 | IPR000917 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.96e-03 | 19 | 65 | 2 | IPR004014 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.96e-03 | 19 | 65 | 2 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 2.18e-03 | 20 | 65 | 2 | PS00132 | |
| Domain | Peptidase_M14 | 2.88e-03 | 23 | 65 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 2.88e-03 | 23 | 65 | 2 | IPR000834 | |
| Domain | PAS-assoc_C | 3.13e-03 | 24 | 65 | 2 | IPR000700 | |
| Domain | PAC | 3.67e-03 | 26 | 65 | 2 | IPR001610 | |
| Domain | PAC | 3.67e-03 | 26 | 65 | 2 | SM00086 | |
| Domain | PAC | 3.67e-03 | 26 | 65 | 2 | PS50113 | |
| Domain | Longin-like_dom | 4.25e-03 | 28 | 65 | 2 | IPR011012 | |
| Domain | hEGF | 4.25e-03 | 28 | 65 | 2 | PF12661 | |
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 38377133 | ||
| Pubmed | A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. | 6.50e-07 | 9 | 70 | 3 | 19966810 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.94e-06 | 183 | 70 | 6 | 31932471 | |
| Pubmed | Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease. | 3.99e-06 | 2 | 70 | 2 | 20554235 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26183928 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17698027 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 38520674 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 34948386 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24718901 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 27466200 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 22183401 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 1827443 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 11786550 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MST1R STK36 ABR ZBED4 CTC1 MTOR HECTD4 PAPLN DNMBP IQGAP3 RYR1 | 1.23e-05 | 1105 | 70 | 11 | 35748872 |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 2.39e-05 | 4 | 70 | 2 | 12209837 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 12784250 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 15101689 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 23413890 | ||
| Pubmed | PSD95beta regulates plasma membrane Ca2+ pump localization at the photoreceptor synapse. | 2.39e-05 | 4 | 70 | 2 | 19233278 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 8094988 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 2.39e-05 | 4 | 70 | 2 | 8245032 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 2.39e-05 | 4 | 70 | 2 | 8634322 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 2.39e-05 | 4 | 70 | 2 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 2.39e-05 | 4 | 70 | 2 | 11152753 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 18201104 | ||
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 2.39e-05 | 4 | 70 | 2 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 2.39e-05 | 4 | 70 | 2 | 10434059 | |
| Pubmed | Association analysis between schizophrenia and the AP-3 complex genes. | 3.98e-05 | 5 | 70 | 2 | 19481122 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 17938178 | ||
| Pubmed | 5.96e-05 | 6 | 70 | 2 | 12763866 | ||
| Pubmed | Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression. | 5.96e-05 | 6 | 70 | 2 | 1352323 | |
| Pubmed | 5.96e-05 | 6 | 70 | 2 | 34633285 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 5.96e-05 | 6 | 70 | 2 | 12767889 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.26e-05 | 38 | 70 | 3 | 30786075 | |
| Pubmed | Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. | 8.33e-05 | 7 | 70 | 2 | 16174644 | |
| Pubmed | 8.33e-05 | 7 | 70 | 2 | 16059920 | ||
| Pubmed | Characterization of the adaptor-related protein complex, AP-3. | 8.33e-05 | 7 | 70 | 2 | 9151686 | |
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 10951186 | ||
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 9545220 | ||
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 24404629 | ||
| Pubmed | 1.25e-04 | 126 | 70 | 4 | 17897319 | ||
| Pubmed | DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. | 1.78e-04 | 10 | 70 | 2 | 18349282 | |
| Pubmed | 1.78e-04 | 10 | 70 | 2 | 27618784 | ||
| Pubmed | 1.78e-04 | 10 | 70 | 2 | 18076669 | ||
| Pubmed | NEDL2 is an essential regulator of enteric neural development and GDNF/Ret signaling. | 2.17e-04 | 11 | 70 | 2 | 25555806 | |
| Pubmed | 2.17e-04 | 11 | 70 | 2 | 22751097 | ||
| Pubmed | 2.60e-04 | 12 | 70 | 2 | 19396169 | ||
| Pubmed | RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes. | 2.60e-04 | 12 | 70 | 2 | 11473323 | |
| Pubmed | 2.60e-04 | 12 | 70 | 2 | 23342162 | ||
| Pubmed | Expression patterns of sulfatase genes in the developing mouse embryo. | 3.07e-04 | 13 | 70 | 2 | 20503373 | |
| Pubmed | 3.58e-04 | 14 | 70 | 2 | 27119228 | ||
| Pubmed | 3.58e-04 | 14 | 70 | 2 | 19850283 | ||
| Pubmed | 4.29e-04 | 313 | 70 | 5 | 20800603 | ||
| Pubmed | 4.71e-04 | 16 | 70 | 2 | 21572416 | ||
| Pubmed | 4.71e-04 | 16 | 70 | 2 | 23247405 | ||
| Pubmed | 5.19e-04 | 183 | 70 | 4 | 23956138 | ||
| Pubmed | 5.33e-04 | 17 | 70 | 2 | 17496333 | ||
| Pubmed | 5.98e-04 | 18 | 70 | 2 | 21998198 | ||
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 5.98e-04 | 18 | 70 | 2 | 33108146 | |
| Pubmed | 6.62e-04 | 84 | 70 | 3 | 15123239 | ||
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 6.62e-04 | 84 | 70 | 3 | 19237606 | |
| Pubmed | 8.18e-04 | 21 | 70 | 2 | 30662561 | ||
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 8.18e-04 | 21 | 70 | 2 | 23063798 | |
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 8.18e-04 | 21 | 70 | 2 | 25249183 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 8.37e-04 | 208 | 70 | 4 | 33230847 | |
| Pubmed | 9.22e-04 | 772 | 70 | 7 | 16341674 | ||
| Pubmed | 9.46e-04 | 215 | 70 | 4 | 35973513 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 9.47e-04 | 95 | 70 | 3 | 29643511 | |
| Pubmed | 1.07e-03 | 24 | 70 | 2 | 19680556 | ||
| Pubmed | Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways. | 1.07e-03 | 24 | 70 | 2 | 20012524 | |
| Pubmed | 1.16e-03 | 102 | 70 | 3 | 10231032 | ||
| Pubmed | 1.16e-03 | 25 | 70 | 2 | 11110696 | ||
| Pubmed | Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis. | 1.26e-03 | 26 | 70 | 2 | 20378664 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.30e-03 | 1321 | 70 | 9 | 27173435 | |
| Pubmed | 1.46e-03 | 28 | 70 | 2 | 18593464 | ||
| Pubmed | 1.51e-03 | 415 | 70 | 5 | 16385451 | ||
| Pubmed | 1.57e-03 | 29 | 70 | 2 | 15071553 | ||
| Pubmed | 1.67e-03 | 30 | 70 | 2 | 27568566 | ||
| Pubmed | Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice. | 1.67e-03 | 30 | 70 | 2 | 28077597 | |
| Pubmed | 1.67e-03 | 30 | 70 | 2 | 32867711 | ||
| Pubmed | 1.81e-03 | 638 | 70 | 6 | 31182584 | ||
| Pubmed | 1.82e-03 | 257 | 70 | 4 | 16335952 | ||
| Pubmed | 1.90e-03 | 32 | 70 | 2 | 24954895 | ||
| GeneFamily | ATPases Ca2+ transporting | 2.46e-04 | 9 | 48 | 2 | 1209 | |
| GeneFamily | Cadherin related | 9.15e-04 | 17 | 48 | 2 | 24 | |
| GeneFamily | Sulfatases | 1.03e-03 | 18 | 48 | 2 | 410 | |
| GeneFamily | Carboxypeptidases | 1.40e-03 | 21 | 48 | 2 | 1321 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.10e-03 | 36 | 48 | 2 | 823 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.05e-03 | 40 | 48 | 2 | 321 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.19e-07 | 199 | 70 | 6 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-06 | 167 | 70 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 8.07e-06 | 174 | 70 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-06 | 177 | 70 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-06 | 177 | 70 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 184 | 70 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 184 | 70 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 184 | 70 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 88 | 70 | 4 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 88 | 70 | 4 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 88 | 70 | 4 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.14e-05 | 187 | 70 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-05 | 190 | 70 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.36e-05 | 194 | 70 | 5 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 196 | 70 | 5 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 196 | 70 | 5 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 196 | 70 | 5 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 198 | 70 | 5 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.58e-05 | 200 | 70 | 5 | 94bd00fb6ff0dcb668eb36ec2085f1c3128855b6 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.58e-05 | 200 | 70 | 5 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.17e-05 | 150 | 70 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.15e-04 | 159 | 70 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.15e-04 | 159 | 70 | 4 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Etv1_(Deep_layer_pyramidal_cells-Etv1_typically_marks_layer_5b,_but_some_expression_in_layer_6,_especially_in_medial_regions_like_cingulate)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 60 | 70 | 3 | f20230c11a2ca2f66650e53ea6eaa301402294c0 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Etv1_(Deep_layer_pyramidal_cells-Etv1_typically_marks_layer_5b,_but_some_expression_in_layer_6,_especially_in_medial_regions_like_cingulate)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 60 | 70 | 3 | 71e2aa3da41319c72b4eac30e54c65e65e62a3d9 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 160 | 70 | 4 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 161 | 70 | 4 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 164 | 70 | 4 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 164 | 70 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 169 | 70 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.45e-04 | 169 | 70 | 4 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e-Inhibitory_Neuron.Gad1Gad2.Sema3e-Kcng4_(GABAergic,_K_Channel_State,_Sema3e+_SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 66 | 70 | 3 | d5e878ffc0b942a35391c7dd73b30cec59f21b39 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e-Inhibitory_Neuron.Gad1Gad2.Sema3e-Kcng4_(GABAergic,_K_Channel_State,_Sema3e+_SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 66 | 70 | 3 | fdb695bbda639112c2f7b714adb7501aef4be19e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 66 | 70 | 3 | de909119de42711b6580274b1200c0e1c6ad2f55 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.59e-04 | 173 | 70 | 4 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-04 | 173 | 70 | 4 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 175 | 70 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 175 | 70 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 176 | 70 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 177 | 70 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 178 | 70 | 4 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 179 | 70 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 179 | 70 | 4 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1-Inhibitory_Gad1Gad2_Htr3a.Phlda1_(Interneuron,__(candidate_CGE-derived_3))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 70 | 70 | 3 | 0f1dba07a2cd974a25239ae1728cfb007a37954c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 70 | 70 | 3 | c579fd093d30a5ee56f7cf1039120d00a6369649 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1-Inhibitory_Gad1Gad2_Htr3a.Phlda1_(Interneuron,__(candidate_CGE-derived_3))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 70 | 70 | 3 | 511ca39208a8a0efd24cca47270083d5024e6972 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 180 | 70 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 180 | 70 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 180 | 70 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 180 | 70 | 4 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 180 | 70 | 4 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-04 | 181 | 70 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 182 | 70 | 4 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-04 | 183 | 70 | 4 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 184 | 70 | 4 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 185 | 70 | 4 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 185 | 70 | 4 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 185 | 70 | 4 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 185 | 70 | 4 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 186 | 70 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 186 | 70 | 4 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.10e-04 | 186 | 70 | 4 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 2.14e-04 | 187 | 70 | 4 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 70 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 70 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 189 | 70 | 4 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 189 | 70 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 189 | 70 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.23e-04 | 189 | 70 | 4 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.23e-04 | 189 | 70 | 4 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 189 | 70 | 4 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-04 | 189 | 70 | 4 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 189 | 70 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-04 | 190 | 70 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-04 | 190 | 70 | 4 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-04 | 190 | 70 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 191 | 70 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-04 | 191 | 70 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-04 | 192 | 70 | 4 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| Drug | gramicidin s | 4.46e-06 | 37 | 68 | 4 | CID000073357 | |
| Drug | FS86 | 8.79e-06 | 2 | 68 | 2 | CID003043275 | |
| Disease | aspartate aminotransferase measurement | TRIM46 CSF1R ATXN1 ERAP2 MTOR HECTD4 CPN1 PPP1R17 DNMBP KIAA2012 | 4.03e-05 | 904 | 68 | 10 | EFO_0004736 |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 7.80e-05 | 6 | 68 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 7.80e-05 | 6 | 68 | 2 | C1854678 | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 7.80e-05 | 6 | 68 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | calpastatin measurement | 1.45e-04 | 8 | 68 | 2 | EFO_0008065 | |
| Disease | CMRF35-like molecule 6 measurement | 1.45e-04 | 8 | 68 | 2 | EFO_0008086 | |
| Disease | Familial hypercholesterolemia | 1.45e-04 | 8 | 68 | 2 | cv:C0020445 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.33e-04 | 10 | 68 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | adseverin measurement | 2.33e-04 | 10 | 68 | 2 | EFO_0801358 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 2.84e-04 | 11 | 68 | 2 | EFO_0021862 | |
| Disease | Congenital myopathy (disorder) | 3.40e-04 | 12 | 68 | 2 | C0270960 | |
| Disease | creatine kinase measurement | 3.47e-04 | 59 | 68 | 3 | EFO_0004534 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 4.68e-04 | 14 | 68 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 5.39e-04 | 15 | 68 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | granulysin measurement | 5.39e-04 | 15 | 68 | 2 | EFO_0008144 | |
| Disease | Hyperlipoproteinemia Type IIa | 6.15e-04 | 16 | 68 | 2 | C0745103 | |
| Disease | neutrophil collagenase measurement | 6.15e-04 | 16 | 68 | 2 | EFO_0008248 | |
| Disease | caudal anterior cingulate cortex volume measurement | 6.96e-04 | 17 | 68 | 2 | EFO_0010289 | |
| Disease | myocardial infarction | 1.29e-03 | 350 | 68 | 5 | EFO_0000612 | |
| Disease | Squamous cell carcinoma of esophagus | 1.39e-03 | 95 | 68 | 3 | C0279626 | |
| Disease | Calcium channel blocker use measurement | 1.50e-03 | 213 | 68 | 4 | EFO_0009930 | |
| Disease | Left Ventricular Hypertrophy | 1.52e-03 | 25 | 68 | 2 | C0149721 | |
| Disease | mean arterial pressure, alcohol drinking | 1.52e-03 | 98 | 68 | 3 | EFO_0004329, EFO_0006340 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 1.64e-03 | 26 | 68 | 2 | OBA_2045194 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.64e-03 | 26 | 68 | 2 | OBA_2045191 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTPVDHPDYPLLQDA | 256 | Q12979 | |
| QDEHPQYHSPPDVVI | 21 | Q9UKF5 | |
| THSPLFHQARPVDYP | 436 | Q6Y288 | |
| EFPPHLDVYIEDPHL | 941 | Q2NKJ3 | |
| RNIPAVDPHLQFYHP | 71 | Q6L9W6 | |
| PPHIIFILTDDQGYH | 46 | Q5FYB1 | |
| VSHHEPESPQLRYLP | 236 | Q9Y6D6 | |
| DNPPRFQHHPYVTHI | 2461 | Q6V0I7 | |
| IVPNHHLPLPTYYTL | 456 | Q96SM3 | |
| SHPHSEQYPDLLPLE | 436 | Q6XZF7 | |
| DVENVPPVISTPHHY | 41 | Q9Y2T2 | |
| SVPHPYESRHVVVHP | 351 | P54253 | |
| HVLSPTLPQYHPLQL | 1316 | Q9Y485 | |
| HIHQLPLQVDPAPDY | 236 | P78312 | |
| NAPLHAPPSEHYTIV | 961 | P20020 | |
| PLHSPPSEHYTIIFN | 986 | Q01814 | |
| LDLPLYPAHPQDFHE | 121 | P30039 | |
| EAENVPPVIPTPHHY | 41 | P53677 | |
| VPPVIHSPNDHVVYE | 241 | Q9NPH3 | |
| SLRPEHHHYPTIDEP | 816 | Q76N89 | |
| IEEFPVPALHHPVFQ | 76 | P16455 | |
| QLVPEHVETRPLYHP | 1441 | A9Z1Z3 | |
| EHSPIQADAKHPFYP | 886 | Q8NCM2 | |
| SPFRIIPYLIHVHHP | 226 | P56645 | |
| IPYLIHVHHPAQPEL | 231 | P56645 | |
| HPPRFTQLHYEASVP | 1551 | Q9NYQ8 | |
| PHPHIHEYLLDPYIS | 636 | Q86V87 | |
| VHPEEVTFHLYLIPS | 1241 | Q9C000 | |
| PTELFILPVEIHYHT | 416 | Q0VF49 | |
| RLHFDSPPHLLDIYP | 316 | Q8TC44 | |
| IFLIHFDPNLHTPIY | 46 | Q8NG92 | |
| TPARLHPHEVYLDPA | 3481 | Q9Y4D8 | |
| HINLPLPAPHAQYAI | 1341 | P42694 | |
| AQDDYRILVHAPHPP | 836 | Q86VI3 | |
| LRNPYHHSLPFSIPV | 1111 | Q8IVE3 | |
| VQFLYPHIESHPLPE | 151 | A4D1B5 | |
| FQVPDLHIPEFQLPH | 2731 | P04114 | |
| HTHPPDEFLFTPVVV | 506 | P07333 | |
| YPLLFNVSIPHHEEV | 126 | O95393 | |
| YVLEFSDHPGIHEPL | 61 | P15169 | |
| PPEFLHETYHANVPE | 156 | P55287 | |
| EHHDFPSIPGYNLPL | 261 | Q6QHC5 | |
| YEVPLETPHVHSRAP | 191 | P10253 | |
| FHTPPSIPLQIEEYL | 281 | P38484 | |
| HKHSVPVYFPAQDPR | 506 | P15848 | |
| SVVIPLHYDLFVHPN | 71 | Q6P179 | |
| HPLLIPYDEDFNHEP | 211 | Q5BKX5 | |
| LPQFEPVPLEHPHYE | 1241 | P21817 | |
| PVPLEHPHYEVSRVD | 1246 | P21817 | |
| VHIFAHEPAHFPPIE | 751 | O94829 | |
| HEPAHFPPIEALFLL | 756 | O94829 | |
| DHPLPTVHPQVTYAY | 1686 | P42345 | |
| FPPHHPLIAVDYQLT | 381 | Q9Y3I0 | |
| EYSEDVHLHTPPAPV | 516 | Q7Z4K8 | |
| HDPLHQEVSFGVPYP | 346 | Q9H0F5 | |
| PEHFHTLPPQAVEFI | 986 | Q587J7 | |
| SPQHYPPREIVAHII | 496 | Q8NDZ2 | |
| PILPHLAEEVFQHIP | 836 | Q9NSE4 | |
| LRDVHHEPVYPQPPF | 426 | Q14181 | |
| VSVHVHPAFTPPYLF | 601 | Q4LDE5 | |
| IHDFPQFYPLGIVQH | 106 | P35244 | |
| PQPHYLLPDTNVLLH | 61 | Q9Y2L1 | |
| PDLLYHPFIAGHVTI | 246 | Q9NRP7 | |
| PEPFHDDIPTESIHY | 126 | O95561 | |
| DVRAHLDHIPDYTPP | 81 | Q8N2M8 | |
| LHIPPFIPGVFSEHL | 71 | O96001 | |
| DYLHLPPEIVPATLH | 81 | Q9NQ39 | |
| EPNPGVHYEYHLPLR | 286 | O95428 | |
| TFHHPVLPARSIQPY | 301 | Q96DM3 | |
| FHYLLGVTPPEELHT | 1516 | Q8IWV7 | |
| IQPGIYHPDIQLLHP | 1306 | Q709C8 | |
| PPYRHIDPFDLTHFL | 1286 | Q04912 | |
| PHLPALHYDEPAENL | 256 | O75132 | |
| YILPPDAVPFVHAHH | 4226 | P20929 |